Uncategorized
Breaking Down Centene: 5 Analysts Share Their Views
Latest Ratings for CNC Date Firm Action From To Feb 2022 Deutsche Bank Maintains Buy Feb 2022 Mizuho Maintains Neutral Jan 2022 Barclays Reinstates Overweight View More Analyst Ratings for CNC View the Latest Analyst Ratings read more
Analyst Expectations For Blueprint Medicines’s Future
Latest Ratings for BPMC Date Firm Action From To Mar 2022 Stifel Maintains Buy Mar 2022 Citigroup Initiates Coverage On Neutral Feb 2022 SVB Leerink Downgrades Outperform Market Perform View More Analyst Ratings for BPMC View the Latest Analyst Ratings read more
Canadian Solar Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Latest Ratings for CSIQ Date Firm Action From To Dec 2021 Citigroup Maintains Buy Nov 2021 Wells Fargo Initiates Coverage On Equal-Weight Aug 2021 GLJ Research Downgrades Buy Sell View More Analyst Ratings for CSIQ View the Latest Analyst Ratings read more
Medicaid Cuts Backlash Grows As Sen. Joni Ernst Tells Voters ‘Well, We All Are Going To Die,’ Mocks Critics From A Cemetery
Senator Joni Ernst faces backlash for dismissing voter’s healthcare concerns with reminder of mortality. read more
Elizabeth Warren Agrees With Trump On Scrapping Debt Limit—But Blasts $4 Trillion Hike For Billionaire Tax Breaks
Sen. Elizabeth Warren (D-Mass.) expressed rare agreement with President Donald Trump on eliminating the federal debt ceiling while sharply criticizing proposed tax breaks for wealthy Americans amid escalating fiscal concerns. read more
‘Nothing Stops This Train’: US Fiscal Deficits Drive Bitcoin’s Case As A Hedge, Says Lyn Alden
Economist Lyn Alden warns that U.S. read more
Eli Lilly Rises 1.5% After Key Trading Signal
A significant trading signal occurred for Eli Lilly stock, as it demonstrated a power inflow at $734.98, after which LLY rose up to 1.5%. read more